Cytiva and Veeda Lifesciences Launch HCP Services...
Category : Licensing/Collaboration Deal 1 December 2025Cytiva, a Danaher company and global life sciences leader, has partnered with Veeda Lifesciences to...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Ascletis Selects ASC37 as Its First Oral Triple Ag...
Category : Clinical Trial Update 1 December 2025Ascletis Pharma has taken a major step in its metabolic disease pipeline by selecting ASC37 oral tab...
Innovent’s Mazdutide 9 mg Moves One Step Closer to...
Category : Clinical Trial Update 28 November 2025China may soon have a powerful new option for treating moderate to severe obesity. Innovent Biologi...
Chugai’s Port Delivery System Hits Key Milestone i...
Category : Clinical Trial Update 28 November 2025A New Long-Term Treatment Option for nAMD and DME Patients Chugai Pharmaceutical has reported res...
Novo Nordisk’s Amycretin Delivers Strong Phase 2 R...
Category : Clinical Trial Update 28 November 2025Novo Nordisk has revealed positive Phase 2 results for amycretin, a new dual-agonist targeting GLP-1...
Latest Newsletter Post
-
Ascletis Selects ASC37 as Its First..
1 December 2025
-
Cytiva and Veeda Lifesciences Launc..
1 December 2025
-
Novo Nordisk’s Amycretin Delivers S..
28 November 2025
-
Chugai’s Port Delivery System Hits..
28 November 2025
-
Innovent’s Mazdutide 9 mg Moves One..
28 November 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com